Global Monkeypox Treatment Market Growth (Status and Outlook) 2023-2029

Global Monkeypox Treatment Market Growth (Status and Outlook) 2023-2029

The global Monkeypox Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Monkeypox Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Monkeypox Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Monkeypox Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Monkeypox Treatment players cover Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd. and Mylan N.V., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.

LPI (LP Information)' newest research report, the “Monkeypox Treatment Industry Forecast” looks at past sales and reviews total world Monkeypox Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Monkeypox Treatment sales for 2023 through 2029. With Monkeypox Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Treatment industry.

This Insight Report provides a comprehensive analysis of the global Monkeypox Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monkeypox Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Oral
Injectable

Segmentation by application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited

Please note: The report will take approximately 2 business days to prepare and deliver.